- Filed
- Apr 30, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 28, 2025 | 52.56M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $153.77M |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $153.61M |
| Short Term Debt | Q1 2025 · Mar 31, 2025 | $0 |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $0 |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $174.35M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $170.43M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $547.13M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $500.7M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $895.54M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $887.06M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $2.62B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $2.59B |
| Total Assets | Q1 2025 · Mar 31, 2024 | $2.48B |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | $2.09B |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $1.98B |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 52.22M sh |
| Dividends Paid | Q1 2025 · Mar 31, 2024 | $30.64M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $104.06M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2024 | $693.86M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2023 | $738.2M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $2.62 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $2.63 |
| Sga Expense restated | Q1 2025 · Mar 31, 2024 | $18.86M |
| Net Income | Q1 2025 · Mar 31, 2024 | $136.99M |
| Operating Income | Q1 2025 · Mar 31, 2024 | $149.08M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $285.59M |